Epigenetic Therapy in a Rare Ovarian Cancer - A Double-Edged Sword

MeSH terms

• Adult
• Antineoplastic Agents* / administration & dosage
• Antineoplastic Agents* / adverse effects
• Benzamides
• Biphenyl Compounds
• DNA Helicases / genetics
• DNA Methylation
• Enhancer of Zeste Homolog 2 Protein / antagonists & inhibitors
• Epigenesis, Genetic* / drug effects
• Female
• Humans
• Morpholines
• Neoplasms, Second Primary* / diagnosis
• Neoplasms, Second Primary* / genetics
• Nuclear Proteins / genetics
• Ovarian Neoplasms* / diagnosis
• Ovarian Neoplasms* / genetics
• Ovarian Neoplasms* / therapy
• Ovariectomy
• Ovary / pathology
• Ovary / surgery
• Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / diagnosis
• Precursor T-Cell Lymphoblastic Leukemia-Lymphoma* / genetics
• Pyridones
• Rare Diseases* / diagnosis
• Rare Diseases* / genetics
• Rare Diseases* / therapy
• Synthetic Lethal Mutations / drug effects
• Transcription Factors / genetics